Proposed response parameters for 12 months drug trial in Juvenile Systemic Sclerosis. Results of the Hamburg International Consensus Meetings

By sjmartinez • June 19, 2023

Foeldvari I, Torok KS, Klotsche J, Anton J, Reis PC, Del Gado F, Denton C, Hinrichs B, Li SC, Pain C, Pilkington C, Cutolo M, Kasapcopur O, Khanna D, Ruperto N, Smith V, Furst DE. Proposed response parameters for 12 months drug trial in Juvenile Systemic Sclerosis. Results of the Hamburg International Consensus Meetings. Arthritis Care Res (Hoboken). 2023 Jun 18. doi: 10.1002/acr.25171. Epub ahead of print. PMID: 37332054.

Tags: Publications, Rheumatology

Needs-Driven Simulation Education: Advancing Neuropalliative Communication for Neurology Residents

Makaroff KE, Hawkins A, Chu N, Aw A, Besbris J, Karlin D, Siegel C. Needs-Driven Simulation Education: Advancing Neuropalliative Communication for Neurology Residents. Am J[...]

Integrin ß4 is a receptor for emerging fungal pathogens from the genera Lomentospora and Scedosporium

Kavaliauskas P, Risteen R, Alkhazraji S, Shirtliff B, Walsh TJ, Ibrahim AS, Bruno VM. Integrin ß4 is a receptor for emerging fungal pathogens from the[...]

“The Evolving Science of Ventilation Heterogeneity: From Pathophysiology to Personalized Therapeutic Approaches”

Barjaktarevic I, Kuhn B, Cooper CB. "The Evolving Science of Ventilation Heterogeneity: From Pathophysiology to Personalized Therapeutic Approaches". Respir Med. 2026 Apr 6:108811. doi: 10.1016/j.rmed.2026.108811.[...]